Clinical Trial Update: Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GB-7624 in healthy adults, sponsored by Generate Biomedicines, with Atopic Dermatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GB-7624

Snippet

Sponsor: Generate Biomedicines | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING